Quantitative evaluation of HIV prevention programs /

How successful are HIV prevention programmes? Which HIV prevention programmes are most cost effective? Which programmes are worth expanding and which should be abandoned altogether? This book addresses the quantitative evaluation of HIV prevention programmes, assessing several different quantitative...

Full description

Saved in:
Bibliographic Details
Other Authors / Creators:Brookmeyer, Ron.
Kaplan, Edward Harris.
Other Corporate Authors / Creators:SIAM Institute for Mathematics and Society.
Format: eBook Electronic
Language:English
Language notes:English.
Imprint: New Haven : Yale University Press, ©2002.
Series:Yale ISPS series.
Subjects:
Online Access:Click here for full text at JSTOR
Table of Contents:
  • Overview of HIV prevention programs in developing countries / Michael H. Merson and Julia M. Dayton
  • Implications of economic evaluations for national HIV prevention policy makers / David R. Holtgrave and Steven D. Pinkerton
  • Statistical issues in HIV prevention / Ron Brookmeyer
  • Epidemiological issues in the evaluation of HIV prevention programs / Nancy S. Padian and Stephen C. Shiboski
  • Difficult choices, urgent needs: optimal investment in HIV prevention programs / Margaret L. Brandeau
  • Methadone treatment as HIV prevention: cost-effectiveness analysis / Harold Pollack
  • Costs and benefits of imperfect HIV vaccines: implications for vaccine development and use / Douglas K. Owens, Donna M. Edwards, and Ross D. Shachter
  • Harm-reduction in Rome: a model-based evaluation of its impact on the HIV-1 epidemic / Massimo Arcà, Teresa Spadea, Giulia Cesaroni, Marina Davoli, Annette D. Verster, and Carlo A. Perucci
  • Evaluating Israel's Ethiopian blood ban / Edward H. Kaplan
  • Feedubg strategies for children of HIV-infected mothers: modeling the trade-off between HIV infection and non-HIV mortality / James G. Kahn, Elliot Marseille, and Joseph Saba
  • Design of HIV trials for estimating external effects / Thomas Philipson
  • Estimation of vaccine efficacy for prophylactic HIV vaccines / Ira M. Longini, Jr., Michael G. Hudgens, and M. Elizabeth Halloran
  • Health policy modeling: epidemic control, HIV vaccines, and risky behavior / Sally Blower, m Katia Koelle, and John Mills
  • Development and validation of a serologic testing algorithm for recent HIV seroconversion / Glen A. Satten, Robert S. Janssen, Susan Stramer, and Michael P. Busch
  • Issues in quantitative evaluation of epidemiologic evidence for temporal variability of HIV infectivity / Stephen C. Shiboski and Nancy S. Padian.